Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Prestige Consumer Healthcare (PBH) Depreciation & Amortization (IS) (2016 - 2025)

Prestige Consumer Healthcare has reported Depreciation & Amortization (IS) over the past 16 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (IS) at $5.1 million for Q4 2025, up 3.81% from a year ago — trailing twelve months through Dec 2025 was $20.6 million (down 6.15% YoY), and the annual figure for FY2025 was $21.3 million, down 5.6%.
  • Depreciation & Amortization (IS) for Q4 2025 was $5.1 million at Prestige Consumer Healthcare, roughly flat from $5.2 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for PBH hit a ceiling of $6.7 million in Q1 2022 and a floor of $5.0 million in Q4 2024.
  • Median Depreciation & Amortization (IS) over the past 5 years was $5.7 million (2024), compared with a mean of $5.8 million.
  • Biggest five-year swings in Depreciation & Amortization (IS): grew 13.83% in 2022 and later decreased 13.65% in 2023.
  • Prestige Consumer Healthcare's Depreciation & Amortization (IS) stood at $6.2 million in 2021, then rose by 0.24% to $6.3 million in 2022, then decreased by 9.94% to $5.6 million in 2023, then decreased by 12.01% to $5.0 million in 2024, then rose by 3.81% to $5.1 million in 2025.
  • The last three reported values for Depreciation & Amortization (IS) were $5.1 million (Q4 2025), $5.2 million (Q3 2025), and $5.2 million (Q2 2025) per Business Quant data.